Update
$Novavax(NVAX.US$ $Moderna(MRNA.US$ Moderna and Novavax Hope for Early Launch of This Year's Covid-19 Shots, Despite FDA Delay -- Barrons.com
Barron's· 3 mins ago
U.S. vaccine makers say that the Food and Drug Administration's delay in designing this fall's Covid-19 vaccines shouldn't push back the rollout of the shots, amid rapid shifts in the genetic makeup of the virus.
Vaccine makers Moderna and Novavax are hoping for an August rollout this year, earlier than last year's late September debut of updated shots. Moderna CEO Stéphane Bancel recently told Barron's that launching the shots in August instead of September could add three million doses to the market.
Barron's· 3 mins ago
U.S. vaccine makers say that the Food and Drug Administration's delay in designing this fall's Covid-19 vaccines shouldn't push back the rollout of the shots, amid rapid shifts in the genetic makeup of the virus.
Vaccine makers Moderna and Novavax are hoping for an August rollout this year, earlier than last year's late September debut of updated shots. Moderna CEO Stéphane Bancel recently told Barron's that launching the shots in August instead of September could add three million doses to the market.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
